Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview
- Demographic Trends
- Demographics by Age
- Demographics by Geographic Distribution
- Organization and Funding of Healthcare
- Overview
- Access to Healthcare
- Public Healthcare Infrastructure
- Corporate Hospital Chains
- Health Insurance
- Voluntary Individual Health Insurance
- Community-Based or Nongovernmental-Organization-Sponsored Health
Insurance
- Employer-Sponsored Coverage
- Government-Sponsored Insurance Programs
- Out-of-Pocket Expenditures
- Pharmaceutical Market Trends
- Historical Development of the Indian Pharmaceutical Market
- Recent Market Trends
- Intellectual Property Rights
- Regulation of the Indian Pharmaceutical Market
- Pharmaceutical Pricing
- Historical Price Controls
- Current Price Control System
- Scheduled Medicines
- Nonscheduled Medicines
- Price Adjustments
- Penalties for Overcharging for Drugs
- International Price Comparison
- Multinational Companies' Pricing Strategies in India
- Distribution Challenges
- Measures to Promote Greater Use of Inexpensive Generics
- Outlook and Implications for the Pharmaceutical Industry
- Encouraging Commercial Outlook Despite Signifi cant Challenges
- Potential Government Reforms
- New Price Controls for Patented Drugs
- Foreign Models for Price Setting
- Expansion of the List of Scheduled Medicines
- Monopoly Purchase of Certain Products
- Signifi cance for Drug Manufacturers
- Opportunities and Threats for Multinationals
Tables
- 1. Rural, Urban, and Major City Populations (thousands), 2008-2018
- 2. International Brands Launched in India, January 2005 to April 2009
- 3. Scheduled Medicines in India
- 4. Ex-Manufacturer Prices of Select Drugs in India and Other Major Markets
as a Percentage of U.S. Prices, 2008
Figures
- 1. Population Breakdown by Age and Sex
- 2. Population Growth, by Age-Group, 2008-2025
- 3. Urban Versus Rural Population Growth, 2008-2025
- 4. Number of Prices Fixed or Revised by the National Pharmaceutical
Pricing Authority, January 2000 to August 2009
- 5. Indian Prices of Select International Brands as a Percentage of the
Respective U.S. Prices, 2008
- 6. Indian Prices of Select International Brands and the Most Frequently
Prescribed Domestic Generic Equivalents
|
Related Report
|
View Cart
